Our screen systematically uncovered mechanisms required for LSD1 inhibitor sensitivity and discovered critical target genes repressed by LSD1 that are required for the ASCL1-driven SCLC neuroendocrine state and survival. The gene discussed is KDM1A; the disease is small cell lung carcinoma.